BBI Solutions OEM Limited of Crumlin at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

BBI Solutions OEM Limited

Unit 2, Parkway, Pen-y-Fan Industrial Estate, NP11 3EF Crumlin
United Kingdom of Great Britain and Northern Ireland
Telephone +44 1495 363000
Fax +44 2920 747242
info@bbisolutions.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 1): stand D37

Fairground map

MEDICA 2021 fairground map: Hall 1

Our range of products

Product categories

Our products

Product category: Immuno assay testing

Introducing BBI Solutions -Serving the Science of Diagnostics

BBI Solutions overview

More Less

Product category: Immuno assay testing

BBI Solutions Products and Services

BBI Solutions is serving the life sciences industry through connected core competencies that include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies. Leveraging our decades of experience in all stages of diagnostic development for the right solutions, the first time.

Browse the attached Products and Services brochure for an overview of BBI Solutions comprehensive product and service offering including

  • Human Antigens
  • Enzymes
  • Serum & Plasma
  • Antibodies
  • Antibody Development
  • Nanoparticles
  • Gold Conjugates
  • Lateral Flow Assay
  • Development &
  • Manufacture
  • Novarum TM   Smartphone Diagnostic Platform

More Less

Product category: Immuno assay testing

Gold Nanoparticles

With over 25 years’ experience of manufacturing high-quality gold nanoparticles, BBI Solutions is the trusted partner for thousands of researchers, testers and manufacturers worldwide.

Every year, our colloidal gold nanoparticles are used in over 400 million assays and are renowned for offering exceptional levels of assay consistency. This is controlled through tight quality control release specifications in relation to gold nanoparticle size, optical properties, morphology and stability.

In summary, we are known for delivering reliable results, batch after batch.

Our specialist gold nanoparticles range in size from 5nm to 250nm, ensuring that you will always have the highest quality of components you need, regardless of the size or nature of your study. These specialist products have been used by our customers in numerous applications, including:

  • Lateral flow assays
  • SEM, TEM, light and dark field microscopy
  • Catalysts
  • Flow cytometry
  • Biosensors
  • Microarrays
  • SERRS applications

More Less

Product category: Immuno assay testing

Hemoglobin A1C HbA1C

Glycosylated hemoglobin A1c (HbA1c) levels are used as an indicator of blood glucose in diabetic patients. It is formed by the conjugation of a hexose sugar to the beta-chain of hemoglobin A. HbA1c builds up in red blood cells throughout their lifetime and its levels therefore represent a record of blood glucose levels over the previous 8 weeks or so. The hemoglobin A1c subunit has a molecular weight of 18kDa.

More Less

Product category: Immuno assay testing

Point of Care Testing Capabilities

 BBI Solutions can support your lateral flow development from concept to commercialisation

Our partnership approach allows you to work with one company to reach your assay goals and bring your concept to reality.

Faster Lateral Flow Development

We understand that getting results quickly is critical for both you and your customers. We have a wealth of expertise in the development of highly responsive point-of-care lateral flow assays, with over 250 successful projects to date.

Whether you are looking to develop a new point-of-care assay or improve an existing diagnostic test, we offer end-to-end services to deliver robust and reproducible tests ready for the global market.

Using high-quality raw materials, we’ll rapidly take your assay from concept to creation, supporting you through development and manufacturing.

Our highly skilled and knowledgeable team has many years of experience developing novel immunoassays that comply with the highest quality and regulatory standards. This lateral flow expertise can be paired with our market-leading gold nanoparticle technology (or your nanoparticle of choice) to deliver the very best outcome for your assay, resulting in a product that will give you a competitive edge.

Expertise:

As part of our full service solution, we have expertise in:

  • Sample preparation – including blood separation and experience in using analytes at various concentration
  • Antibody/antigen selection
  • Detector label selection – including gold, latex, paramagnetic and fluorescent particles
  • Numerous conjugation techniques – such as sandwich, competitive and inhibition assays
  • Nitrocellulose membrane selection
  • Test strip architecture and chemistry
  • Reader solutions
Whether you require a complete outsourced service or just an initial feasibility evaluation, we can provide consultation and customised lateral development packages to accommodate most sample matrices, applications and budgets.

Our modular approach means you can select the level of development that suits your needs. For customers looking for a complete ‘turnkey’ assay development, an indicative timeline for a project will take from 12 to 15 months and follows our robust approach.

We’re certified to ISO 13485, and have vast experience of working on lateral flow assay development projects that require FDA approval. A dedicated team of scientists work exclusively on your assay to ensure rapid progress. At the end of the development cycle, we will hand over the design history file, so that you fully own your test.

Talk to us today to learn how we are shaping the future of lateral flow assay development.

More Less

Product category: Immuno assay testing

Lateral Flow Services

For over 25 years BBI Solutions has been a trusted OEM partner for the development and manufacture of lateral flow assays.

The core mission of BBI Solutions is to deliver exceptional service and technologies to improve the quality of life for all people.

With that core value in mind, we have continuously expanded our portfolio of OEM services and brought first to market innovations such as our Novarum mobile diagnostic platform.

The acquisition of Maine Biotechnology Services (MBS) brings to BBI Solutions a technical team with broad
expertise and experience in collaborative project planning ready to create goal-driven development of
antibodies for any application.

Why BBI?

Whether you require the complete outsourced service or just one of our services, we offer a partnership approach which allows you to work with one company to reach your assay goals. We can provide a customised package accommodating most applications or budget, creating a robust and reproducible test ready for the global market. Using high-quality raw materials, we’ll rapidly take your assay from concept to creation, supporting you through every step of development and manufacture.

Our highly skilled and knowledgeable team has many years of experience developing novel immunoassays that comply with the highest quality and regulatory standards. This lateral flow expertise can be paired with our market-leading gold nanoparticle technology (or detector label of your choice) to deliver the very best outcome for your assay, resulting in a product that will give you a competitive edge.

At BBI Solutions, we offer robust and flexible manufacturing options. We cater to routine manufacturing production at a range of production batch sizes and for spiked demand or supply as part of a disaster recovery program. Browse our catalogue for a detailed overview of our suite of OEM services for IVD development.

Our unique combination of custom antibody development, lateral flow development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.

Lateral Flow services include:
  • Antibody Development
  • Lateral Flow Assay
  • Development & Manufacture
  • Reader Technology
  • Mobile Diagnostic Platform
Please see the attached Lateral Flow Services Brochure to find out more.

More Less

About us

Company portrait

BBI Solutions has been serving the global diagnostics industry for over 50 years, and is the the world’s largest independent producer of immuno-diagnostics reagents.

We develop and manufacture critical components for the diagnostic industry, but also apply our expertise by delivering solutions that bring critical components together in the development and manufacture of point of care and conventional tests.

Furthermore, our Novarum Mobile Diagnostic Platform complements across the diagnostics workflow to interpret and share assay results. This makes BBI unique among IVD suppliers. 

Our range of immuno-diagnostics reagents includes human antigens, antibodies, enzymes and serum & plasma products.

 With manufacturing sites spanning four continents, we produce world-renowned labels for lateral flow, ELISA assay and biosensors, including our high-quality gold nanoparticles and glucose oxidase.

 The acquisition of German-based DIARECT AG in June 2020 established BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets.

BBI Solutions is part of the BBI Group.
Website: www.bbisolutions.com
E-mail: info@bbisolutions.com
Tel: +44 (0) 1495 363 000